Can COMT Inhibitors Improve Cognitive Functions in Patients with Parkinson??s Disease?
- 1 April 2000
- journal article
- Published by Springer Nature in CNS Drugs
- Vol. 13 (4) , 227-232
- https://doi.org/10.2165/00023210-200013040-00001
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Slowing of reaction time in Parkinsons disease: theinvolvement of the frontal lobesNeuropsychologia, 1999
- Inhibitors of catecholamine metabolizing enzymes cause changes in S-adenosylmethionine and S-adenosylhomocysteine in the rat brainNeurochemistry International, 1998
- Tolcapone added to levodopa in stable parkinsonian patients: A double‐blind placebo‐controlled studyMovement Disorders, 1997
- Cognitive improvement during Tolcapone treatment in Parkinson's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1997
- Catechol 0-methyltransferase inhibitor tolcapone has minor influence on performance in experimental memory models in ratsBehavioural Brain Research, 1997
- Peripheral and central inhibitors of catechol-O-methyl transferase: effects on liver and brain COMT activity and L-DOPA metabolismJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1997
- Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction.Journal of Neurology, Neurosurgery & Psychiatry, 1994
- ‘FRONTAL’ COGNITIVE FUNCTION IN PATIENTS WITH PARKINSON'S DISEASE ‘ON’AND ‘OFF’ LEVODOPABrain, 1988
- Properties of novel effective and highly selective inhibitors of catechol-O-methyltransferaseLife Sciences, 1988
- FRONTAL LOBE DYSFUNCTION IN PARKINSON'S DISEASEBrain, 1986